Abbvie, Androgel partner owe $488 million in antitrust case: U.S. judge

(Reuters) - A U.S. judge on Friday found that Abbvie Inc used sham litigation to illegally prevent generic versions of testosterone gel AndroGel from getting to market and ordered the drugmaker and its partner to pay $488 million.

Source: Reuters: Health - June 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news